Artwork

Inhoud geleverd door Sal Daher. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Sal Daher of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !

Todd Zion, PhD - More Magical Proteins

45:31
 
Delen
 

Manage episode 378751353 series 2519822
Inhoud geleverd door Sal Daher. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Sal Daher of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

Angel Scale Biotech: Learn More

Repeat founder Todd Zion, PhD is back to update us on exciting developments at his second biotech startup, Akston Bio. We also geeked out a bit on how these magical proteins are concocted in the company’s bioreactors. Fun and instructive chat with a stellar founder.

Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson.

Highlights:

  • Sal Daher Introduces Todd Zion
  • Akston Bio's Founding Story
  • "... The antigen in this case is the person's own insulin..."
  • "... you're still taking advantage of that antibody portion, but you've neutered it so that it no longer alerts the immune system, but it retains one property that antibodies all have, which is the ability to recycle and last for very long periods of time in circulation..."
  • "... We took the veterinary candidates and we partnered those with a company called Dechra Pharmaceuticals, PLC. They're one of the leaders in veterinary pharma development and this is all in the public domain..."
  • "... We made a pivot at that point saying, 'Well, what if we just go back to the portion of the antibody that interacts with the immune system and make ourselves a vaccine against COVID-19 using the same exact technology?'..."
  • "... you're going to continue involved in manufacturing, or are you just going to buckle down in the veterinary space and spin off these other technologies to other players?..."
  • "... if you're not pivoting at least once in your development, you're probably doing something wrong..."
  • Todd's Funding History
  • "... what goes on in a bioreactor, which is the heart of what you're doing? Geek out a little bit of bioreactors..."
  • "... there are these companies that do nothing but transfect CHO cells to produce particular types of protein..."
  • Energesis

Topics: biotech, COVID, discovering entrepreneurship

  continue reading

310 afleveringen

Artwork
iconDelen
 
Manage episode 378751353 series 2519822
Inhoud geleverd door Sal Daher. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Sal Daher of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

Angel Scale Biotech: Learn More

Repeat founder Todd Zion, PhD is back to update us on exciting developments at his second biotech startup, Akston Bio. We also geeked out a bit on how these magical proteins are concocted in the company’s bioreactors. Fun and instructive chat with a stellar founder.

Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson.

Highlights:

  • Sal Daher Introduces Todd Zion
  • Akston Bio's Founding Story
  • "... The antigen in this case is the person's own insulin..."
  • "... you're still taking advantage of that antibody portion, but you've neutered it so that it no longer alerts the immune system, but it retains one property that antibodies all have, which is the ability to recycle and last for very long periods of time in circulation..."
  • "... We took the veterinary candidates and we partnered those with a company called Dechra Pharmaceuticals, PLC. They're one of the leaders in veterinary pharma development and this is all in the public domain..."
  • "... We made a pivot at that point saying, 'Well, what if we just go back to the portion of the antibody that interacts with the immune system and make ourselves a vaccine against COVID-19 using the same exact technology?'..."
  • "... you're going to continue involved in manufacturing, or are you just going to buckle down in the veterinary space and spin off these other technologies to other players?..."
  • "... if you're not pivoting at least once in your development, you're probably doing something wrong..."
  • Todd's Funding History
  • "... what goes on in a bioreactor, which is the heart of what you're doing? Geek out a little bit of bioreactors..."
  • "... there are these companies that do nothing but transfect CHO cells to produce particular types of protein..."
  • Energesis

Topics: biotech, COVID, discovering entrepreneurship

  continue reading

310 afleveringen

Alle Folgen

×
 
Loading …

Welkom op Player FM!

Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.

 

Korte handleiding